Nicholas Martino, APRN
Primary Care · Lake City, FLNPI 1346010204
Payments from drug & device makers
Across 38 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$158
- Merck$115
- Novartis$68
- Johnson & Johnson$52
- Takeda Pharmaceuticals U.S.A., Inc.$52
- Endo USA, Inc.$46
- plus $341 from 13 others
What the payments were for
- Food & beverage$831100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 6 | $158 |
| Merck | 5 | $115 |
| Novartis | 4 | $68 |
| Johnson & Johnson | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Endo USA, Inc. | 2 | $46 |
| Bayer | 2 | $44 |
| Exelixis Inc. | 2 | $39 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Coloplast | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $26 |
| Eisai Inc. | 1 | $22 |
| Pharmaessentia USA Corporation | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Novocure Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
How this compares
$831 in reported general payments places this provider in the 65th percentile of 725 primary care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 48 | $1,687 |
| Tamsulosin Hcl | 47 | $821 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $425 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $277 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $106 |
| Ciprofloxacin Hcl | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other primary care in Lake City
- Elizabeth NewmanLake City$8K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Maria Rodriguez ReyesHialeah$31K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.